Bratton Capital Management, L.P.
Bratton Capital Management, L.P. is a hedge fund based in Fort Worth, Texas. Operating as a registered investment adviser, the firm manages institutional money and reports regulatory filings to the SEC. Its filings date back at least to 2019, and it serves a range of institutional clients, with a reported focus on equity positions. The firm manages approximately $33 million in assets as of the June 2025 quarterly 13F filing. The exact year of founding is not specified in publicly available filings. Employee count and further firm background are not disclosed.
Investment Strategy
Bratton Capital Management, L.P. primarily invests in public equities, with recent regulatory filings indicating a concentrated portfolio focused heavily on biotechnology and specialty pharmaceutical companies. The firm's holdings are dominated by Aquestive Therapeutics (AQST), comprising 100% of its disclosed portfolio, suggesting a highly focused and possibly opportunistic investment approach. The strategy appears to target growth and value opportunities in underfollowed or high-potential segments of the healthcare sector. Detailed investment philosophy or risk profile is not publicly available.
Top Holdings
Equity Positions (1)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A AQST | AQUESTIVE THERAPEUTICS INC | 100.00% | $32.5M | 9,810,958 | $6.30 | $3.31 | +$4.0M |